The Value of In Vitro Diagnostic Testing in Medical Practice: A Status Report
Open accessThe DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
Abstract
BACKGROUND: In vitro diagnostic (IVD) investigations are indispensable for routine patient management. Appropriate testing allows early-stage interventions, reducing late-stage healthcare expenditure (HCE). AIM: To investigate HCE on IVDs in two developed markets and to assess the perceived value of IVDs on clinical decision-making. Physician-perceived HCE on IVD was evaluated, as well as desired features of new diagnostic markers. METHODS: Past and current HCE on IVD was calculated for the US and Germany. A total of 79 US/German oncologists and cardiologists were interviewed to assess the number of cases where: physicians ask for IVDs; IVDs are used for initial diagnosis, treatment monitoring, or post-treatment; and decision-making is based on an IVD test result. A sample of 201 US and German oncologists and cardiologists was questioned regarding the proportion of HCE they believed to be attributable to IVD testing. After disclosing the actual IVD HCE, the physician's perception of the appropriateness of the amount was captured. Finally, the association between physician-rated impact of IVD on decision-making and perceived contribution of IVD expenditure on overall HCE was assessed. RESULTS: IVD costs account for 2.3% and 1.4% of total HCE in the US and Germany. Most physicians (81%) believed that the actual HCE on IVDs was >5%; 19% rated the spending correctly (0-4%, p<0.001). When informed of the actual amount, 64% of physicians rated this as appropriate (p<0.0001); 66% of decision-making was based on IVD. Significantly, more physicians asked for either additional clinical or combined clinical/health economic data than for the product (test/platform) alone (p<0.0001). CONCLUSIONS: Our results indicate a poor awareness of actual HCE on IVD, but a high attributable value of diagnostic procedures for patient management. New markers should deliver actionable and medically relevant information, to guide decision-making and foster improved patient outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“A significant proportion, 66 %, of clinical decisionmaking is based on in vitro diagnostics (IVD) [15].”
From Machine learning-based clinical decision support using laboratory data (2024) · cites this paper as [15]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods for the Economic Evaluation of Health Care Programmes
Drummond, M. E., Sculpher, M. J., Torrance, G. W., O’Brien, B. J., & Stoddart, G. L. (2005) · doi:10.1093/oso/9780198529446.001.0001 · Cited by 13,648
Porter, M. E. (2010) · New England Journal of Medicine · doi:10.1056/nejmp1011024 · Cited by 5,084
Schnipper, L. E., Davidson, N. E., Wollins, D. S., Tyne, C., Blayney, D. W., Blum, D., Dicker, A. P., Ganz, P. A., Hoverman, J. R., Langdon, R., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.6706 · Cited by 912
The cervical cancer epidemic that screening has prevented in the UK
Peto, J., Gilham, C., Fletcher, O., & Matthews, F. E. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16674-9 · Cited by 808
Errors in clinical laboratories or errors in laboratory medicine?
Plebani, M. (2006) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2006.123 · Cited by 734
HER2 testing in gastric cancer: a practical approach
Rüschoff, J., Hanna, W., Bilous, M., Hofmann, M., Osamura, R. Y., Penault-Llorca, F., van de Vijver, M., & Viale, G. (2012) · Modern Pathology · doi:10.1038/modpathol.2011.198 · Cited by 595
The Landscape of Inappropriate Laboratory Testing: A 15-Year Meta-Analysis
Zhi, M., Ding, E. L., Theisen-Toupal, J., Whelan, J., & Arnaout, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078962 · Cited by 535 · cited 1×
“Interestingly is also the fact that there were four times as many studies found on over- compared to underutilization during the assessed 15-year period and, despite in-depth literature research, only 42 studies finally matched the criteria for review, indicating a poor level of evidence on inappropriate use of IVD te…”
ResultThe detection and prevention of errors in laboratory medicine
Plebani, M. (2010) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1258/acb.2009.009222 · Cited by 479
Jeremias, A., & Gibson, C. M. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-9-200505030-00015 · Cited by 466
Redefining Competition in Health Care
Hester, C. (2004) · Harvard business review · Cited by 384
Research works printed but not linked: 2
- Raman G, Avendano E, Chen M. Update on Emerging Genetic Tests Currently Available for Clinical Use in Common Cancers, in Technology Assessment Report Rockville, MD: Agency for Healthcare Research and Quality; 2013. 25905153
- Quest Diagnostics 31st Annual J. P. Morgan Healthcare Conference January 9, 2013. Available: http://ir.questdiagnostics.com/phoenix.zhtml?c=82068&p=irol-presentations.
Cited by
Access to pathology and laboratory medicine services: a crucial gap
Wilson, M. L., Fleming, K. A., Kuti, M. A., Looi, L. M., Lago, N., & Ru, K. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30458-6 · Cited by 444
A guide to aid the selection of diagnostic tests
Kosack, C. S., Page, A.-L., & Klatser, P. R. (2017) · Bulletin of the World Health Organization · doi:10.2471/blt.16.187468 · Cited by 415
Nucleic Acid Detection Using CRISPR/Cas Biosensing Technologies
Aman, R., Mahas, A., & Mahfouz, M. (2020) · ACS Synthetic Biology · doi:10.1021/acssynbio.9b00507 · Cited by 409
Point-of-care testing based on smartphone: The current state-of-the-art (2017–2018)
Liu, J., Geng, Z., Fan, Z., Liu, J., & Chen, H. (2019) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2019.01.068 · Cited by 335
Point-of-care testing: applications of 3D printing
Chan, H. N., Tan, M. J. A., & Wu, H. (2017) · Lab on a Chip · doi:10.1039/c7lc00397h · Cited by 168
Cadamuro, J., Cabitza, F., Debeljak, Z., De Bruyne, S., Frans, G., Perez, S. M., Ozdemir, H., Tolios, A., Carobene, A., & Padoan, A. (2023) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2023-0355 · Cited by 116
“Laboratory medicine has always struggled with the fact thatalthoughitcontributestothemajorityofmedicaldecisions with its test results [1 – 3], it is rarely able to interpret these resultsinthecontextofthepatient ’ sclinic,especiallywhenthis information is usually not provided by the requesting…”
BackgroundMetabolic Fingerprinting on a Plasmonic Gold Chip for Mass Spectrometry Based in Vitro Diagnostics
Sun, X., Huang, L., Zhang, R., Xu, W. L., Huang, J., Gurav, D. D., Vedarethinam, V., Chen, R., Lou, J., Wang, Q., et al. (2018) · ACS Central Science · doi:10.1021/acscentsci.7b00546 · Cited by 121
Frequency that Laboratory Tests Influence Medical Decisions
Ngo, A., Gandhi, P., & Miller, W. G. (2017) · The Journal of Applied Laboratory Medicine · doi:10.1373/jalm.2016.021634 · Cited by 91
Klebes, A., Ates, H. C., Verboket, R. D., Urban, G. A., von Stetten, F., Dincer, C., & Früh, S. M. (2023) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2023.115800 · Cited by 94
Clinical Applications of Visual Plasmonic Colorimetric Sensing
Mauriz, E. (2020) · Sensors · doi:10.3390/s20216214 · Cited by 86
Park, R., Jeon, S., Jeong, J., Park, S., Han, D., & Hong, S. W. (2022) · Biosensors · doi:10.3390/bios12030136 · Cited by 91
“The market growth for IVD devices can be attributed to the increasing proportion of the geriatric population and technological advancement in diagnostics [4].”
BackgroundEffectiveness of Practices to Support Appropriate Laboratory Test Utilization
Rubinstein, M. L., Hirsch, R. P., Bandyopadhyay, K., Madison, B. M., Taylor, T. H., Ranne, A., Linville, M. L., Donaldson, K. J., Lacbawan, F. L., & Cornish, N. E. (2017) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqx147 · Cited by 93
“Additionally, with increased capitation and restrictive insurance reimbursements, clinical laboratories are under continuous pressure to improve the value and utility of laboratory investigations while operating in relation to these financial restrictions.(3,4) Within this landscape, rates of inappropriate overutiliza…”
BackgroundCancer of unknown primary—Epidemiological trends and relevance of comprehensive genomic profiling
Binder, C., Matthes, K. L., Korol, D., Rohrmann, S., & Moch, H. (2018) · Cancer Medicine · doi:10.1002/cam4.1689 · Cited by 87
Self-citationChang, H., Zúñiga, A., Conejero, I., Voyvodic, P. L., Gracy, J., Fajardo-Ruiz, E., Cohen‐Gonsaud, M., Cambray, G., Pageaux, G., Meszaros, M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25538-y · Cited by 87
An Essential Pathology Package for Low- and Middle-Income Countries
Fleming, K. A., Naidoo, M., Wilson, M. L., Flanigan, J. S., Horton, S., Kuti, M. A., Looi, L., Price, C., Ru, K., Ghafur, A. K., et al. (2016) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqw143 · Cited by 90
“Indeed, a recent interview-based study of cardiologists and oncologists in Germany and the United States has indicated that 66% of clinical decisions are based on results from in vitro diagnostic tests.(3) However, pathology also supports clinical care by assessing disease severity and prognosis (eg, determining the s…”
BackgroundEnhancing the Clinical Value of Medical Laboratory Testing.
Sikaris, K. A. (2017) · Europe PMC (PubMed Central) · Cited by 119
Xu, Y., Xin, J., Zhou, Y., Ma, M., Wang, M., & Ying, B. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.704077 · Cited by 78
“Currently, the routine diagnostics for infectious pathogen are bacterial culture, polymerase chain reaction (PCR) and immunological detection (Lampel et al., 2000; Byrne et al., 2009; Arvanitis et al., 2014; Rohr et al., 2016; Balmaseda et al., 2017).”
BackgroundMachine learning-based clinical decision support using laboratory data
Çubukçu, H. C., Topcu, D. İ., & Yenice, S. (2024) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2023-1037 · Cited by 66
“A signi fi cant proportion, 66 %, of clinical decision-making is based on in vitro diagnostics (IVD) [15].”
BackgroundThe persistence of carbon in the African forest understory
Hubau, W., Mil, T. D., den Bulcke, J. V., Phillips, O. L., Ilondea, B. A., Acker, J. V., Sullivan, M. J. P., Nsenga, L., Toirambe, B., Couralet, C., et al. (2019) · Nature Plants · doi:10.1038/s41477-018-0316-5 · Cited by 72
Duchesne, L., Houle, D., Ouimet, R., Caldwell, L., Gloor, M. U., & Brienen, R. (2019) · Scientific Reports · doi:10.1038/s41598-019-43243-1 · Cited by 58
Bioanalytical Requirements and Regulatory Guidelines for Immunoassays
Vashist, S. K., & Luong, J. H. T. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811762-0.00004-9 · Cited by 53
Plasmonic Janus hybrids for the detection of small metabolites
Su, H., Liu, T., Huang, L., Huang, J., Cao, J., Yang, H., Ye, J., Liu, J., & Qian, K. (2018) · Journal of Materials Chemistry B · doi:10.1039/c8tb01587b · Cited by 55
Designed Microdevices for In Vitro Diagnostics
Sun, X., Wan, J., & Qian, K. (2017) · Small Methods · doi:10.1002/smtd.201700196 · Cited by 52
Meyer, A., Cadamuro, J., Lippi, G., & Šimundić, A.-M. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.03.043 · Cited by 52
Improving American Healthcare Through “Clinical Lab 2.0”
Crawford, J. M., Shotorbani, K. R., Sharma, G., Crossey, M., Kothari, T., Lorey, T. S., Prichard, J. W., Wilkerson, M. L., & Fisher, N. (2017) · Academic Pathology · doi:10.1177/2374289517701067 · Cited by 49
Fluorescence Signal-Readout of CRISPR/Cas Biosensors for Nucleic Acid Detection
Huang, Z., Liu, S., Pei, X., Li, S., He, Y., Tong, Y., & Liu, G. (2022) · Biosensors · doi:10.3390/bios12100779 · Cited by 49
Central role of laboratory medicine in public health and patient care
Olver, P., Bohn, M. K., & Adeli, K. (2022) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2022-1075 · Cited by 74
Engineered Noble-Metal Nanostructures for in Vitro Diagnostics
Xi, Z., Ye, H., & Xia, X. (2018) · Chemistry of Materials · doi:10.1021/acs.chemmater.8b04152 · Cited by 50
Dimensional measurement of TiO2 (Nano) particles by SAXS and SEM in powder form
Ghomrasni, N. B., Taché, O., Leroy, J., Feltin, N., Testard, F., & Chivas‐Joly, C. (2021) · Talanta · doi:10.1016/j.talanta.2021.122619 · Cited by 41
Inappropriateness in laboratory medicine: an elephant in the room?
Lippi, G., Bovo, C., & Ciaccio, M. (2017) · Annals of Translational Medicine · doi:10.21037/atm.2017.02.04 · Cited by 41
“This is noticeably confirmed by recent data attesting that up to 70% of the clinical decisions are substantially based on results of diagnostic tests (1).”
BackgroundImproving diagnosis and reducing diagnostic errors: the next frontier of laboratory medicine
Plebani, M., & Lippi, G. (2016) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2016-0217 · Cited by 41
Ultra‐Fast Label‐Free Serum Metabolic Diagnosis of Coronary Heart Disease via a Deep Stabilizer
Zhang, M., Huang, L., Yang, J., Xu, W. L., Su, H., Cao, J., Wang, Q., Pu, J., & Qian, K. (2021) · Advanced Science · doi:10.1002/advs.202101333 · Cited by 39
Khosla, N. K., Lesinski, J. M., Colombo, M., Bezinge, L., deMello, A. J., & Richards, D. A. (2022) · Lab on a Chip · doi:10.1039/d2lc00609j · Cited by 42
Conrad, K., Shoenfeld, Y., & Fritzler, M. J. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102508 · Cited by 35
A lightweight xAI approach to cervical cancer classification
Civit-Masot, J., Luna-Perejón, F., Muñoz-Saavedra, L., Domínguez-Morales, M., & Civit, A. (2024) · Medical & Biological Engineering & Computing · doi:10.1007/s11517-024-03063-6 · Cited by 37
Li, J., Yang, C., Wang, W., & Yan, X. (2018) · Nanoscale · doi:10.1039/c8nr04414g · Cited by 33
Torrisi, S. E., Palmucci, S., Stefano, A., Russo, G. I., Torcitto, A. G., Falsaperla, D., Gioè, M., Pavone, M., Vancheri, A., Sambataro, G., et al. (2018) · Multidisciplinary Respiratory Medicine · doi:10.1186/s40248-018-0155-2 · Cited by 35
Kidney injury biomarkers in an academic hospital setting: where are we now?
van Duijl, T. T., Ruhaak, L. R., de Fijter, J. W., & Cobbaert, C. M. (2019) · Clinical Biochemist Reviews · doi:10.33176/aacb-18-00017 · Cited by 40
The Value Proposition for Pathologists: A Population Health Approach
Ducatman, B. S., DUCATMAN, A. M., Crawford, J. M., Laposata, M., & Sanfilippo, F. P. (2020) · Academic Pathology · doi:10.1177/2374289519898857 · Cited by 38
“A recent literature review, with physician specialist interviews and an Internet-based multiple choice survey, estimated that an average of 74% of cardiology and oncology patients in the United States had laboratory tests, which influenced an average of 64% of medical decisions.(3) Laboratory tests were most often use…”
BackgroundBasaleh, A. S., & Sheta, S. M. (2021) · Journal of Inorganic and Organometallic Polymers and Materials · doi:10.1007/s10904-021-01888-4 · Cited by 29
Stavelin, A. V., & Sandberg, S. (2023) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2023.2262029 · Cited by 31
“It has been reported that two out of three medical decisions are based on laboratory results [2]. therefore, reliable and accurate test results are crucial.”
BackgroundTang, Y., Duan, F., Zhou, A., Kanitthamniyom, P., Luo, S., Hu, X., Jiang, X., Vasoo, S. S., Zhang, X., & Zhang, Y. (2022) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10428 · Cited by 32
“logical samples extracted from bodily fluids or solid tissues, in order to detect the presence of pathogens, identify medical disorders, and monitor a person's health status or response to treatment.(1) IVD plays”
BackgroundThe Cost-Effective Laboratory: Implementation of Economic Evaluation of Laboratory Testing
Bogavac‐Stanojević, N., & Jelić‐Ivanović, Z. (2017) · Journal of Medical Biochemistry · doi:10.1515/jomb-2017-0036 · Cited by 26
“3% of total healthcare expenditure (3, 4) and less than 5% of total hospital cost (Lewin Group report) (5).”
BackgroundHicks, A. J., Carwardine, Z. L., Hallworth, M. J., & Kilpatrick, E. S. (2020) · Biochemia Medica · doi:10.11613/bm.2021.010703 · Cited by 26
“A 2016 study of laboratory use by oncologists and cardiologists found that 75% of all their patients underwent laboratory testing, and that this testing led to a substantial clinical decision in 66% of the patients (4).”
BackgroundPreparing Laboratories for Interconnected Health Care
Bietenbeck, A., & Streichert, T. (2021) · Diagnostics · doi:10.3390/diagnostics11081487 · Cited by 34
“Since up to 80% of clinical decisions are affected by in vitro diagnostics [8], these expert interpretations can improve patient safety, timely diagnosis, and treatments [9].”
BackgroundIntegrating quality control and external quality assurance
Badrick, T. C. (2021) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2021.05.003 · Cited by 49
Surface modification for improving immunoassay sensitivity
Zhou, X., & Zheng, B. (2023) · Lab on a Chip · doi:10.1039/d2lc00811d · Cited by 28
Variations in seasonal drought tolerance rankings
Banks, J. M., Percival, G., & Rose, G. (2019) · Trees · doi:10.1007/s00468-019-01842-5 · Cited by 24
Savari, M., Khaleghi, B., & Sheheytavi, A. (2025) · Environmental and Sustainability Indicators · doi:10.1016/j.indic.2025.100581 · Cited by 26
Swanson, K., Dodd, M., VanNess, R., & Crossey, M. (2018) · The Journal of Applied Laboratory Medicine · doi:10.1373/jalm.2017.025379 · Cited by 23
“data (4, 5) and that clinical data provide the best”
BackgroundPathology Services in Nigeria: Cross-Sectional Survey Results From Three Cancer Consortia
Ntiamoah, P., Monu, N. R., Abdulkareem, F. B., Adeniji, K. A., Obafunwa, J. O., Komolafe, A. O., Yates, C. C., Kaninjing, E. T., Carpten, J. D., Salhia, B., et al. (2019) · Journal of Global Oncology · doi:10.1200/jgo.19.00138 · Cited by 30
“Clinicians depend heavily on pathologic findings to assess severity, prognosis, and potential treatments for these cancers.(1,16) Nigeria has seen an improvement in the number of pathologists per population(17,18); however, the majority of pathology services remain rudimentary compared with high-income countries, and…”
BackgroundPaediatric Reference Intervals: Current Status, Gaps, Challenges and Future Considerations
Hoq, M., Matthews, S. J., Donath, S. M., Carlin, J. B., Ignjatović, V., & Monagle, P. (2020) · Clinical Biochemist Reviews · doi:10.33176/aacb-19-00036 · Cited by 32
Viral load detection and management on first line ART in rural Rwanda
Ntwali, J. D. D. N., Decroo, T., Ribakare, M., Kiromera, A., Mugwaneza, P., Nsanzimana, S., & Lynen, L. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-018-3639-y · Cited by 21
A model to establish autoverification in the clinical laboratory
Topçu, D. İ., & Gülbahar, Ö. (2021) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2021.03.018 · Cited by 20
Arzideh, F., Özcürümez, M. K., Albers, E., Haeckel, R., & Streichert, T. (2021) · Journal of Laboratory Medicine · doi:10.1515/labmed-2020-0149 · Cited by 20
“Clinical decisions are affected by in vitro diagnostics in up to 70% [20].”
BackgroundCost, profitability and value of laboratory diagnostics: in God we trust, all others bring data
Lippi, G., & Plebani, M. (2019) · Journal of Laboratory Medicine · doi:10.1515/labmed-2018-0321 · Cited by 19
Advances in point-of-care testing for cardiovascular diseases
Regan, B., O’Kennedy, R. J., & Collins, D. A. (2020) · Advances in clinical chemistry · doi:10.1016/bs.acc.2020.09.001 · Cited by 19
Ran, C., Zhang, J., He, X., Luo, C., Zhang, Q., Shen, Y., & Yin, L. (2024) · Talanta · doi:10.1016/j.talanta.2024.126936 · Cited by 18
Fasano, T., Bedini, J. L., Fle, P.-A., Jlaiel, M., Hubbert, K., Datta, H. K., Chicha-Cattoir, V., Mansour, H., Mira, Á., de la Presa, B. G., et al. (2019) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2019-0699 · Cited by 21
“A recent study reported that in vitro diagnostic tests influence about 70% of medical decisions [1].”
BackgroundLaboratory economics. Risk or opportunity?
Lippi, G., & Plebani, M. (2016) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2016-0313 · Cited by 17
Roadblocks of Urinary EV Biomarkers: Moving Toward the Clinic
Droste, M., Puhka, M., van Royen, M. E., Ng, M. S. Y., Blijdorp, C. J., Álvarez‐Llamas, G., Borràs, F. E., Büscher, A. K., Bussolati, B., Dear, J. W., et al. (2025) · Journal of Extracellular Vesicles · doi:10.1002/jev2.70120 · Cited by 21
“A recent study noted that more than 80% of health care practitioners believe that the costs of in vitro diagnostic tests are higher than they actually are (Rohr et al. 2016).”
Electrochemical immunosensor for the quantification of galectin-3 in saliva
Pittman, T. W., Zhang, X., Punyadeera, C., & Henry, C. S. (2023) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2023.134811 · Cited by 17
Thelen, M., Vanstapel, F. J. L. A., Brguljan, P. M., Gouget, B., Boursier, G., Barrett, E., Κroupis, C., Lohmander, M., Šprongl, L., Vodnik, T., et al. (2018) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2018-1212 · Cited by 17
Cheng, M. M., Palma, J. F., Scudder, S., Poulios, N., & Liesenfeld, O. (2017) · Journal of Personalized Medicine · doi:10.3390/jpm7030005 · Cited by 15
“Along with the proliferation of many new targeted cancer therapies, there has also been a proliferation in the number of highly complex molecular diagnostic tests that detect clinically relevant tumor biomarkers and aid in the identification of patients for targeted therapy [5].”
BackgroundMixture density networks for the indirect estimation of reference intervals
Hepp, T., Zierk, J., Rauh, M., Metzler, M., & Seitz, S. (2022) · BMC Bioinformatics · doi:10.1186/s12859-022-04846-0 · Cited by 15
“Background In vitro diagnosis plays an important role in routine clinical practice and patient management with approximately 66% of medical decisions supported by the corresponding test results [1].”
BackgroundPhuphisut, O., Poodeepiyasawat, A., Yoonuan, T., Watthanakulpanich, D., Thawornkuno, C., Reamtong, O., Sato, M., & Adisakwattana, P. (2024) · Parasites & Vectors · doi:10.1186/s13071-024-06134-7 · Cited by 14
“Currently, several companies and research groups have developed prototype portable fluorescent signal readouts for RPA– CRISPR/Cas detection [51–54].”
BackgroundUnlocking the potential of chitosan in immunoassay sensor
Jin, Z., Huang, G., Song, Y., Zheng, X., & Zhao, K. (2024) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2024.123024 · Cited by 14
Prospective applications of ultrahigh resolution proteomics in clinical mass spectrometry
Ruhaak, L. R., van der Burgt, Y. E. M., & Cobbaert, C. M. (2016) · Expert Review of Proteomics · doi:10.1080/14789450.2016.1253477 · Cited by 14
Data mining of pediatric reference intervals
Zierk, J., Metzler, M., & Rauh, M. (2021) · Journal of Laboratory Medicine · doi:10.1515/labmed-2021-0120 · Cited by 17
How do we use the data from pre-analytical quality indicators and how should we?
Cadamuro, J., Gaksch, M., Mrazek, C., Haschke‐Becher, E., & Plebani, M. (2018) · Journal of Laboratory and Precision Medicine · doi:10.21037/jlpm.2018.04.04 · Cited by 14
“Laboratory test results contribute to the majority of diagnoses and clinical decision making in most health care settings (9).”
BackgroundCassidy, C. E., Sim, M., Somerville, M., Crowther, D., Sinclair, D. E., Rose, A. E., Burgess, S., Best, S., & Curran, J. (2022) · PLoS ONE · doi:10.1371/journal.pone.0273149 · Cited by 16
García-Castrillo, L., Cadamuro, J., Dodt, C., Lauwaert, D., Hachimi-Idrissi, S., van der Linden, C., Bergs, J., Costelloe, S. J., Grossmann, F. F., Koca, A., et al. (2024) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2024-0059 · Cited by 15
Simultaneous detection of protein and nucleic acid biomarkers with a CRISPR-based assay
Zhang, Y., Cheng, Y., Zhao, C., Chen, J., Wu, Z., Wang, J., & Wang, L. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.158452 · Cited by 11
Badrick, T. C., Gutscher, A., Sakamoto, N., & Chin, D. (2017) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2017.03.017 · Cited by 13
“In vitro diagnostics (IVDs) have long been considered as the “silent champion” of healthcare, influencing over 60 % of clinical decision-making, while accounting for only about 2 % of total healthcare spending [1].”
BackgroundHallworth, M. J. (2018) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563218773778 · Cited by 11
Medical ethics in laboratory medicine: A review, with an oath for pathologists
Bhagwat, S. N., & Pai, S. A. (2020) · Indian Journal of Medical Ethics · doi:10.20529/ijme.2020.02 · Cited by 11
“The significance of laboratory medicine is seen from the fact that 66 % of clinical decisions were based on laboratory tests as shown by a recent study (1).”
BackgroundPathology and Laboratory Medicine in cancer care: A global analysis of national cancer control plans
Parra‐Herran, C., Romero, Y., & Milner, D. A. (2020) · International Journal of Cancer · doi:10.1002/ijc.33384 · Cited by 11
“4% of the overall health-care expenditure in these countries, respectively.(14) Having adequate PALM resources has also a significant economic impact in the system, and it has been shown to be a highly costeffective strategy at the population level.”
BackgroundBahati, F., McKnight, J., Swaleh, F., Malaba, R., Karimi, L., Ramadhan, M., Kiptim, P. K., Okiro, E. A., & English, M. (2022) · PLoS ONE · doi:10.1371/journal.pone.0266667 · Cited by 14
“Evidence shows that 60–70% of clinical decisions depend on laboratory diagnosis [3, 4].”
BackgroundReturning Individual Research Results to Vulnerable Individuals
Kolarcik, C. L., Bledsoe, M. J., & O’Leary, T. J. (2022) · American Journal Of Pathology · doi:10.1016/j.ajpath.2022.06.004 · Cited by 20
Casas, M. L. M. D. L., Esteban, Á., González‐Muñoz, M., Labrador‐Horrillo, M., Pascal, M., & Teniente‐Serra, A. (2020) · Advances in Laboratory Medicine / Avances en Medicina de Laboratorio · doi:10.1515/almed-2020-0051 · Cited by 14
Synthetic biology-based portable in vitro diagnostic platforms
Geraldi, A., & Giri-Rachman, E. A. (2018) · Alexandria Journal of Medicine · doi:10.1016/j.ajme.2018.11.003 · Cited by 11
“In vitro diagnostic (IVD) test, in which examination is performed on specimens taken from the human body, is an indispensable tool for producing high-quality medical outcomes.(1,2) Such tests are critical for diagnosing and monitoring of diseases, providing prognosis and predicting treatment response, as well as, asse…”
BackgroundMethodDendroecology of Pinus elliottii Engelm. reveals waves of invasion in a neotropical savanna
Brandes, A. F. D. N., Albuquerque, R. P., Domingues, G. D. A. F., Barros, C. F., Durigan, G., & de Abreu, R. C. R. (2019) · Biological Invasions · doi:10.1007/s10530-019-02099-2 · Cited by 10
Mrosewski, I., Dähn, T., Hehde, J., Kalinowski, E., Lindner, I., Meyer, T. M., Olschinsky-Szermer, M., Pahl, J., Puls, M., Sachse, K., et al. (2021) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2021-0853 · Cited by 10
High-Quality Diagnosis: An Essential Pathology Package
Fleming, K. A., Naidoo, M., Wilson, M. L., Flanigan, J. S., Horton, S., Kuti, M. A., Looi, L., Price, C. P., Ru, K., Ghafur, A. K., et al. (2017) · World Bank, Washington, DC eBooks · doi:10.1596/978-1-4648-0527-1_ch11 · Cited by 12
Projecting Forest Dynamics Across Europe: Potentials and Pitfalls of Empirical Mortality Algorithms
Thrippleton, T., Hülsmann, L., Cailleret, M., & Bugmann, H. K. M. (2019) · Ecosystems · doi:10.1007/s10021-019-00397-3 · Cited by 12
Findeisen, P., Zahn, I., Fiedler, M., Leichtle, A. B., Wang, S., Soria, G., Johnson, P. G., Henzell, J., Hegel, J. K., Bendavid, C., et al. (2018) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2018.05.019 · Cited by 9
Heparin and citrate additive carryover during blood collection
Keppel, M. H., Auer, S., Lippi, G., Meyer, A., Cornes, M. P., Felder, T. K., Oberkofler, H., Mrazek, C., Haschke‐Becher, E., & Cadamuro, J. (2019) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2019-0433 · Cited by 10
“Introduction Laboratory diagnostics has evolved into an indispensable part in diagnosis and monitoring of patients in almost every health care setting [1].”
BackgroundBenchmarking medical laboratory performance on a global scale
Huf, W., Mohns, M., Almeta, E., Lister, R., Buchta, C., Demyanets, S., Buchberger, W., & Ettl, B. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1363957 · Cited by 12
Liu, Y., Cai, Q., Qin, C., Jin, Y., Wang, J., Yang, C., Ouyang, Y., Li, H., & Liu, S. (2020) · Microchimica Acta · doi:10.1007/s00604-020-04630-y · Cited by 8
Laboratory medicine: The exemplar for value-based healthcare
Arshoff, L., Hoag, G. N., Ivany, C., & Kinniburgh, D. W. (2021) · Healthcare Management Forum · doi:10.1177/0840470421990041 · Cited by 8
The digital transformation of laboratory medicine: From instruments to intelligence
Adeli, K. (2025) · LabMed discovery. · doi:10.1016/j.lmd.2025.100095 · Cited by 7
Measuring the impact: Severity of harm from laboratory errors in 195 tests
Çubukçu, H. C., Cihan, M., Hakan, H., Bolat, S., Zengi, O., Uçar, K. T., Topçu, D. İ., Kılınçkaya, M. F., Özdemir, H., Gülşen, M., et al. (2024) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqae144 · Cited by 7
Benchmarking diagnostic laboratory performance: Survey results for Germany, Austria, and Switzerland
Huf, W., Mohns, M., Garmatiuk, T., Lister, R., Buchta, C., Ettl, B., & Köller, U. (2021) · Wiener klinische Wochenschrift · doi:10.1007/s00508-021-01962-4 · Cited by 9
Huf, W., Mohns, M., Bünning, Z., Lister, R., Garmatiuk, T., Buchta, C., & Ettl, B. (2022) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2021-1349 · Cited by 12
“The latter influences the majority of clinical decisions, while accounting for only about 2% of direct healthcare cost [4, 5].”
BackgroundEhrler, F., Tuor, C., Trompier, R., Berger, A., Ramusi, M., Rey, R., & Siebert, J. N. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12030428 · Cited by 11
“Centers for Disease Control and Prevention [32], laboratory tests are ordered in nearly 48% of ED visits, and 70% of medical decisions today are based on these [33], thus showing their important contribution in emergency care.”
BackgroundThe Real Value of Laboratory Medicine
Price, C. P., & John, A. S. (2016) · The Journal of Applied Laboratory Medicine · doi:10.1373/jalm.2016.020313 · Cited by 7
“A recent interview-based study involving oncologists and cardiologists in the US and Germany concluded that approximately 66% of clinical decisions were guided by the results from in vitro diagnostic tests (7).”
BackgroundCurrent Progresses of Functional Nanomaterials for Imaging Diagnosis and Treatment of Melanoma
Zhu, C., Zhu, Y., Pan, H., Chen, Z., & Zhu, Q. (2019) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026619666191023130524 · Cited by 7
Strategies for energy conservation and sustainability in medical laboratories
Jovičić, S. Ž., & Milinković, N. (2025) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2025.2527284 · Cited by 9
Principles of ideal diagnostic regulation and the IVDR
Hallersten, A., Decker, N. M., & Huang, Y. (2022) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2022-1206 · Cited by 6
Ding, Y., Pei, C., Li, K., Shu, W., Hu, W., Li, R., Zeng, Y., & Wan, J. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1118911 · Cited by 6
“In vitro diagnostics (IVD) contributes to about 70% of clinical diagnoses, thereby often referring to the “eyes” of doctors (Rohr et al., 2016;Wishart, 2016).”
Background
Metadata
- Authors
- Rohr, U.-P., Binder, C., Dieterle, T., Giusti, F., Messina, C. G. M., Toerien, E., Moch, H., & Schäfer, H. H.
- Affiliations
- University Hospital Zurich (CH)
- Kantonsspital Baselland (CH)
- European Organisation for Research and Treatment of Cancer (NL)
- F. Hoffmann-La Roche AG (CH)
- Corresponding author
- Schäfer, Hans Hendrik
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2016-03-04
- Volume
- 11
- Issue
- 3
- Pages
- e0149856
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4778800
- OpenAlex
- W2291253625
- Cited by
- 229
- References
- 44
- Citations by year
- 2026: 15 · 2025: 21 · 2024: 43 · 2023: 22 · 2022: 18 · 2021: 23 · 2020: 22 · 2019: 21 · 2018: 20 · 2017: 14 · 2016: 10
- FWCI
- 40.31
- Type
- journal article
- Language
- en
- Update notices
- correction (2016-04-14)
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- edoc (University of Basel) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- UpSpace Institutional Repository (University of Pretoria) (submittedVersion, cc-by)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, cc-by)
- Zurich Open Repository and Archive (University of Zurich)
- Topics
- Health Sciences › Health Professions › General Health Professions › Healthcare cost, quality, practices
- Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Keywords
- health care expenditure, physician perceptions, clinical decision-making, diagnostic biomarkers, cost awareness, clinical management
- MeSH terms
- Algorithms, Cardiology, Cost-Benefit Analysis, Data Collection, Diagnostic Tests, Routine, Germany, Humans, Medical Oncology, Practice Patterns, Physicians', Surveys and Questionnaires, United States, Health Care Costs, Decision Support Systems, Clinical
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.